REFERENCES
- Boyarsky, S. 1967. Rationale for drug therapy in bladder dysfunction. In Neurogenic bladder, pp. 187–190. Williams and Wilkins, Baltimore.
- Finkbeiner, A., Bissada, N. & Welch, L. 1977. Uropharmacology: Part VI. Parasympathetic depressants. Urology 10, 503.
- Hilwa, N. & Perlmutter, A. 1978. The role of adjunctive drug therapy for intermittent catheterization and self-catheterization in children with vesical dysfunction. J Urol 119, 551.
- Lapides, J. 1959. Urinary incontinence. Med Clin N Amer 43, 1629.
- Lapides, J., Diokno, A. C., Gould, F. R. & Lowe, B. S. 1976. Further observations on self-catheterization. J Urol 116, 169.
- Meyers, F. H., Javets, E. & Goldfien, A. 1976. Parasympatholytic drugs. In Review of medical pharmacology, 5th ed., pp. 69–77. Lange Medical Publication, Los Altos, California.
- Mulcahy, J., James, H. & McRoberts, W. 1977. Oxybutynin chloride combined with intermittent clean catheterization in the treatment of myelomeningocele patients. J Urol 118, 95.
- Naglo, A.-S., Boréus, L. O., Hellström, B. & Nergårdh, A. 1979. Is beta-receptor blockade of value in continence training of children? Scand J Rehab Med 11, 63.
- Naglo, A.-S. & Nergårdh, A. 1981. Diagnosis of hyperactivity in children with neurogenic bladder. Scand J Urol Nephrol 15, 91.
- Naglo, A.-S., Nergårdh, A. & Boréus, L. O. 1981. Influence of atropine and isoprenaline on detrusor hyperactivity in children with neurogenic bladder. Scand J Urol Nephrol 15, 97.
- Nergårdh, A., v. Hedenberg, Ch., Hellström, B. & Ericsson, N. O. 1974. Continence training of children with neurogenic bladder dysfunction. Dev Med Child Neurol 16, 47.
- Nergårdh, A. & Naglo, A.-S. 1981. Observations on the internal sphincter mechanism during the filling phase in children with hyperactive neurogenic bladder. In manuscript.
- Raezer, D., Benson, G., Wein, A. & Duckett, J. 1977. The functional approach to the management of the pediatric neuropathic bladder. A clinical study. J Urol 117, 649.
- Schoenberg, H., Shah, J. & Gregory, J. 1977. Pharmacologic modification of therapeutic measures used in managing the neurogenic bladder. Birth Defects 13, 123.
- Stockamp, K., Herrmann, H. & Schreiter, F. 1976. Conservative bladder treatment in myelodysplasia. Urol Int 31, 93.
- Taira, N. 1972. The autonomic pharmacology of the bladder. An Rev Pharmacol 12, 197.
- Ursillo, R. 1967. Rationale for drug therapy in bladder dysfunction. In Neurogenic bladder (ed. S.Boyarsky), pp. 187–190. Williams and Wilkins, Baltimore.